SK Capital completes acquisition of Apotex, a global leader in affordable pharmaceuticals
TORONTO, April 3, 2023 /PRNewswire/ - Apotex Pharmaceutical Holdings Inc. ("Apotex" or the "Company") today announced that its acquisition by an affiliate of funds advised by SK Capital Partners, LP ("SK Capital") has closed.
- TORONTO, April 3, 2023 /PRNewswire/ - Apotex Pharmaceutical Holdings Inc. ("Apotex" or the "Company") today announced that its acquisition by an affiliate of funds advised by SK Capital Partners, LP ("SK Capital") has closed.
- The Company also announces that experienced pharmaceutical executive Allan Oberman has been appointed President and CEO and member of the Board of Apotex.
- Allan brings four decades of experience in corporate leadership to Apotex, including 20 years in the pharmaceutical industry.
- Most recently, he served as CEO of Concordia International Corp. and CEO of Sagent Pharmaceuticals Inc.